![Marc Abrams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Marc Abrams worked as a Senior Vice President-Discovery Research at Dicerna Pharmaceuticals, Inc. from 2021 to 2023.
He received his graduate degree from the University of Rochester, his doctorate from Thomas Jefferson University, and his undergraduate degree from Drexel University.
Precedenti posizioni note di Marc Abrams
Società | Posizione | Fine |
---|---|---|
DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/01/2023 |
Formazione di Marc Abrams
Thomas Jefferson University | Doctorate Degree |
Rochester Christian University | Graduate Degree |
Drexel University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Dicerna Pharmaceuticals, Inc.
![]() Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Marc Abrams